Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Enterprise Value came in at -$45000.0 in Q4 2025, down 136.84% year-on-year from $122142.9 in Q4 2024, and down 1400.0% quarter-over-quarter from -$3000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Enterprise Value (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Enterprise Value across 6 years of filings, most recently posting -$45000.0 for Q4 2025.
- Enterprise Value for Q4 2025 came in at -$45000.0, down 136.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$45000.0 (down 136.84% YoY), and the FY2025 annual result was -$45000.0, down 136.84% from the prior year.
- Enterprise Value came in at -$45000.0 for Q4 2025 at Raphael Pharmaceutical, down from -$3000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3000.0 in Q3 2025 to a low of -$299000.0 in Q3 2023.
- The 5-year median for Enterprise Value is -$87000.0 (2022), against an average of -$113833.3.
- Across the five-year window, Enterprise Value sank 655.26% in 2024 and jumped 92.5% in 2025, its largest moves.
- Raphael Pharmaceutical's Enterprise Value stood at -$153000.0 in 2021, then plunged by 88.24% to -$288000.0 in 2022, then climbed by 20.14% to -$230000.0 in 2023, then surged by 91.74% to -$19000.0 in 2024, then plunged by 136.84% to -$45000.0 in 2025.
- The last three Enterprise Value figures came in at -$45000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$20000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | Raphael Pharmaceutical | - | - | - | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | -230,000.00 |
| Sep 30, 2023 | -299,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | -288,000.00 |
| Sep 30, 2022 | -93,000.00 |
| Jun 30, 2022 | -135,000.00 |
| Mar 31, 2022 | -81,000.00 |
| Dec 31, 2021 | -153,000.00 |
| Sep 30, 2021 | -37,000.00 |
| Dec 31, 2020 | -95,000.00 |
| Sep 30, 2020 | -36,000.00 |